should we treat acute respiratory distress syndrome with inhaled nitric oxide

2(respective survival rate of 80 and 100%), and despite the recommendations of the American-European acute respiratory distress syndrome (ARDS) consensus, 3 no study has been appropriately designed to address the clinical outcome of ARDS patients treated with inhaled nitric oxide (NO). This pilot randomised controlled clinical trial of ARDS patients was implemented to study the efficacy of inhaled NO on lung function; the impact of inhaled NO on morbidity and mortality; and the feasibility of conducting a large multicentre trial. 30 established ARDS (with lung injury score 4